CN104688768A - External ulcer powder - Google Patents
External ulcer powder Download PDFInfo
- Publication number
- CN104688768A CN104688768A CN201310644462.2A CN201310644462A CN104688768A CN 104688768 A CN104688768 A CN 104688768A CN 201310644462 A CN201310644462 A CN 201310644462A CN 104688768 A CN104688768 A CN 104688768A
- Authority
- CN
- China
- Prior art keywords
- grams
- vitamin
- external
- ulcer
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to an external ulcer powder, which is characterized by including: 15% of oxytetracycline, 15% of berberine, 10% of compound sulfamethoxazole, 10% of metronidazole, 15% of composite vitamin B, 15% of vitamin C, 10% of cimetidine, 7% of calcium, and 3% of chlorpheniramine. The external ulcer powder provided by the invention solves the problem that existing external ulcer powder is inapplicable to treatment of bedsore and other skin mucosa ulcer, scalds, non healing wounds and other diseases, and is suitable for treatment of various infantile febrile convulsion patients.
Description
Technical field
The present invention relates to the preparation field of medicine, is a kind of prescription for skin ulcer treatment specifically.
Background technology
Common external-use ulcer medicine has significant limitation on therapeutic effect, does not particularly substantially have effect to oral ulcer, can not be used for the mucocutaneous ulcers such as decubital ulcer and the treatment of the illness such as scald, non-healing wounds.
Summary of the invention
The present invention is the problem that the current external-use ulcer medicine of solution can not be used for the mucocutaneous ulcers such as decubital ulcer and the treatment of the illness such as scald, non-healing wounds, invents a kind of external-use ulcer powder medicament.
Technical scheme of the present invention is, a kind of external-use ulcer powder, and to be component be its special character: oxytetracycline, berberine, bactrim, metronidazole, compound vitamin B, vitamin C, cimetidine, calcium, chlorphenamine;
Its component ratio is: oxytetracycline 15%, berberine 15%, bactrim 10%, metronidazole 10%, compound vitamin B 15%, vitamin C 15%, cimetidine 10%, calcium 7%, chlorphenamine 3%;
When manufacturing, get mentioned component in proportion, pulverize crosses No. 6 sieve mix homogeneously subpackages.During use, this medicated powder end is coated with the affected part be sprinkling upon through sterilization, is advisable to cover wound face at every turn.
Technique effect of the present invention is, adopts technique scheme, realizes a kind ofly treating the splendid medicament of ulcer effect, within two to four days, just can cure general wound.
Specific embodiment
embodiment 1,fetch earth mycin 15 grams, berberine 15 grams, bactrim 10 grams, metronidazole 10 grams, compound vitamin B 15 grams, vitamin C 15 grams, cimetidine 10 grams, calcium 7 grams, chlorphenamine 3 grams; Pulverize crosses No. 6 sieve mix homogeneously can become 100 grams of compound recipe KUIYANG SAN.
embodiment 2,fetch earth mycin 30 grams, berberine 30 grams, bactrim 20 grams, metronidazole 20 grams, compound vitamin B 30 grams, vitamin C 30 grams, cimetidine 20 grams, calcium 14 grams, chlorphenamine 6 grams; Pulverize crosses No. 6 sieve mix homogeneously can become 200 grams of compound recipe KUIYANG SAN.
embodiment 3,fetch earth mycin 60 grams, berberine 60 grams, bactrim 40 grams, metronidazole 40 grams, compound vitamin b6 0 gram, vitamin C 60 grams, cimetidine 40 grams, calcium 28 grams, chlorphenamine 12 grams; Pulverize crosses No. 6 sieve mix homogeneously can become 400 grams of compound recipe KUIYANG SAN.
Claims (1)
1. an external-use ulcer powder, is characterized in that component is: oxytetracycline, berberine, bactrim, metronidazole, compound vitamin B, vitamin C, cimetidine, calcium, chlorphenamine; Component ratio is: oxytetracycline 15%, berberine 15%, bactrim 10%, metronidazole 10%, compound vitamin B 15%, vitamin C 15%, cimetidine 10%, calcium 7%, chlorphenamine 3%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310644462.2A CN104688768A (en) | 2013-12-05 | 2013-12-05 | External ulcer powder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310644462.2A CN104688768A (en) | 2013-12-05 | 2013-12-05 | External ulcer powder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104688768A true CN104688768A (en) | 2015-06-10 |
Family
ID=53336594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310644462.2A Pending CN104688768A (en) | 2013-12-05 | 2013-12-05 | External ulcer powder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104688768A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022123305A1 (en) * | 2020-12-07 | 2022-06-16 | S.L.A. Pharma Ag | Compositions comprising metronidazole for treatment of diabetic foot ulcers and venous ulcers |
-
2013
- 2013-12-05 CN CN201310644462.2A patent/CN104688768A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022123305A1 (en) * | 2020-12-07 | 2022-06-16 | S.L.A. Pharma Ag | Compositions comprising metronidazole for treatment of diabetic foot ulcers and venous ulcers |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103830267A (en) | Compound external anti-ulcer tablet | |
| CN105311332A (en) | Ulcer stopping and tissue regeneration promoting powder | |
| CN104688768A (en) | External ulcer powder | |
| CN106474148A (en) | A kind of external-use ulcer composite medicine | |
| CN105640979A (en) | Ulcer treating powder for external use | |
| CN102908408A (en) | Bedsore plaster | |
| CN103127473A (en) | Pain-relieving paste | |
| CN105641337A (en) | Compound Yushang ointment | |
| CN107929312A (en) | A kind of external-use ulcer composite medicine | |
| CN107753524A (en) | Compound wound plaster | |
| CN107875206A (en) | A kind of compound wound plaster | |
| CN105770120A (en) | Traditional Chinese medicine formula for treating humid eczema dermatitis | |
| CN103340954B (en) | Medicament for treating burn and scald | |
| CN107308379A (en) | A kind of Chinese medicine for treating rhinitis | |
| CN103550160A (en) | Anti-inflammatory drug powder | |
| CN101352450A (en) | Prescription of compound external-use ulcer powder | |
| CN104666362A (en) | Composite callus ointment | |
| CN103182011A (en) | Millipede ulcer and sore plaster | |
| CN109865015A (en) | A kind of Chinese medicine preparation for treating humid tetter dermatitis | |
| CN106729208A (en) | One kind treats psoriasic Traditional chinese medicine medicament formula | |
| CN104083496A (en) | Drug for treating burn | |
| CN104367646A (en) | Traditional Chinese medicine for treating hypochondriac pain externally | |
| KR20200075335A (en) | Skin disease treatment | |
| UA69674U (en) | method for treatment of erythematous-bullous erysipelas | |
| CN103070984A (en) | Preparation method of traditional Chinese medicine used for treating seborrheic dermatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150610 |